A highly mutated variant of the SARS-CoV-2 virus, which causes COVID-19, has been detected in a number of countries. The variant, called BA.3.2, was first detected in South Africa way back in November ...

The world map shows the countries and regions for which master data analyses for SARS-CoV-2 are available. The darker the red, the more data is available. The data comes from GISAID and the WHO. Since ...

Experts explain why this particular strain is more likely to overcome immunity from vaccination or previous infection.

An international research team has identified a previously overlooked factor that influences how antibodies neutralize ...

Researchers from Lawrence Livermore National Laboratory (LLNL), in collaboration with other leading institutions, have successfully used an AI-driven platform to preemptively optimize an antibody to ...

As we approach the five-year anniversary of the COVID-19 pandemic, it is worth reflecting not only on the paradigm-shifting impact of the initial outbreak, but also on how SARS-CoV-2 continues to ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors. Blocking this interaction with inhibitors could prevent ...

The BA.3.2 'Cicada' Covid variant has been detected in 23 countries with over 70 mutations. Here's what experts say about its spread, symptoms, severity and vaccine protection.

A detailed genomic investigation of a Denver Zoo outbreak shows how SARS-CoV-2 can rapidly diversify and adapt after crossing species, offering a rare real-world view of viral evolution beyond humans.

UCSF researchers designed new drug candidates that potently block MPro, a viral enzyme that's crucial for SARS-CoV-2 replication. One of these drug candidates, AVI-4516, is shown (center) bound to the ...